Clinical Trials Browser

Rogaratinib × Tumor-Agnostic × Clear all

NCT03517956 2022-07-14

ROCOCO

Phase 1 Completed

Neoplasm Metastasis

NCT03788603 2021-03-29

Rogaratinib (BAY1163877) in Chinese Patients

Phase 1 Completed

Neoplasms

NCT02592785 2018-04-18

Phase I Dose Escalation Study of BAY 1163877 (Rogaratinib) in Japanese Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Neoplasms